Dundalk, Ireland site is recognized for its regulatory compliance and product safety.
WuXi Biologics, a contract research, development, and manufacturing organization (CRDMO), has been awarded a 2023 Facility of the Year Award (FOYA) in the Operations category by the International Society for Pharmaceutical Engineering (ISPE). The CRDMO was recognized for using innovative solutions while complying with regulatory requirements, overcoming unknown barriers, and upholding project success and product safety at its manufacturing facility in Dundalk, Ireland.
The 467,500-square-foot plant features two manufacturing areas that use 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch. Construction of the site began in December 2018, while operations commenced in December 2021. In nine months, the facility was able to receive its first good manufacturing practice (GMP) certificate from the Irish Health Products Regulatory Authority (HPRA).
Following WuXi Biologics’ environmental, social, and governance (ESG) strategy, sustainable concepts were implemented into the site’s construction and operations, including reducing energy use and recycling resources. Currently, 100 percent of power supply comes from renewable energy at the Ireland site.
“This recognition by ISPE is a testament to our team’s dedication and relentless pursuit of excellence. It also signifies success for our clients, partners, and local community, and, ultimately, for the patients who rely on the life-saving biologics manufactured at our Ireland site,” says Brendan McGrath, VP and head of WuXi Biologics’ Ireland site.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Boosting Patient Adherence: The Power of Clinical Support Programs
October 3rd 2024In this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.